KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Net Cash Flow: 2018-2024

Historic Net Cash Flow for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $20.9 million.

  • Castle Biosciences' Net Cash Flow fell 64.60% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 351.69%. This contributed to the annual value of $20.9 million for FY2024, which is 186.56% up from last year.
  • Castle Biosciences' Net Cash Flow amounted to $20.9 million in FY2024, which was up 186.56% from -$24.1 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Net Cash Flow ranged from a high of $311.0 million in FY2020 and a low of -$206.7 million during FY2022.
  • Over the past 3 years, Castle Biosciences' median Net Cash Flow value was -$24.1 million (recorded in 2023), while the average stood at -$70.0 million.
  • In the last 5 years, Castle Biosciences' Net Cash Flow skyrocketed by 229.58% in 2020 and then tumbled by 157.65% in 2022.
  • Yearly analysis of 5 years shows Castle Biosciences' Net Cash Flow stood at $311.0 million in 2020, then slumped by 125.79% to -$80.2 million in 2021, then tumbled by 157.65% to -$206.7 million in 2022, then surged by 88.34% to -$24.1 million in 2023, then skyrocketed by 186.56% to $20.9 million in 2024.